Cormorant Asset Management, LP Axsome Therapeutics, Inc. Transaction History
Cormorant Asset Management, LP
- $1.27 Billion
- Q4 2024
A detailed history of Cormorant Asset Management, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 325,000 shares of AXSM stock, worth $44.8 Million. This represents 2.17% of its overall portfolio holdings.
Number of Shares
325,000
Previous 400,000
18.75%
Holding current value
$44.8 Million
Previous $35.9 Million
23.49%
% of portfolio
2.17%
Previous 2.52%
Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$558 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$455 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$202 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$191 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.91B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...